Gore has joined with leaders across the vascular and endovascular community in honouring four North American physicians as 2014 Pioneers in Performance. The biennial award acknowledges exceptional work in the field of vascular and endovascular therapy, including aortic and lower-limb bypass and dialysis access surgery.
The 2014 nominees were selected by past award recipients in four categories that correspond with different aspects of clinical collaboration. Through popular vote on the Pioneers in Performance website, the broader medical community chose to award the following honourees at a special celebration during the 41st VEITHsymposium held in New York, USA (November 18-22, 2014).
The Pioneers in Performace are as follows:
Commitment to ongoing learning – Jose I Almeida, vascular surgeon and founder of the Miami Vein Center, Miami, Florida;
Dedication to sharing knowledge with peers and patients – Jaafer Golzar, interventional cardiologist at Advocate Christ Medical Center, Chicago, Illinois;
Dedication to creating consensus within the medical community – Michael R Jaff, professor of medicine at Harvard Medical School, Boston, Massachusetts;
Dedication to analysis of clinical outcomes – Herbert D Aronow, director of the comprehensive vascular programme at St Joseph Mercy Hospital, Ann Arbor, Michigan.
Symposium chair, Frank Veith, commented: “This year’s award recipients are of the finest in our industry and exemplify what it means to be a true pioneer in the pursuit to advance open and endovascular surgery and improve patient outcomes.” Veith is also professor of surgery at Cleveland Clinic and New York University and the William J. von Liebig chair in vascular surgery at New York Medical Center.
“Each year, we support the extraordinary achievements made by vascular and endovascular physicians from all over the world through Pioneers in Performance and this year is no exception as we congratulate the 2014 North American honourees,” said David Abeyta, Leader of the Gore Medical Products Division. “It is with this honour that we thank all the participants for their unrelenting dedication to advancing vascular and endovascular therapy for their patients and their peers.”